Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Cancer. 2020 Sep 14;126(23):5050–5059. doi: 10.1002/cncr.33176

Figure 1.

Figure 1.

Unadjusted Mean Adherence and Out-of-Pocket Payments by Hospital Referral Region.

Unadjusted mean adherence and out-of-pocket payments by hospital referral region (HRR). Those HRRs with at least 11 patients receiving abiraterone or enzalutamide during the study timeframe (134 HRRs) were included and listed along the X-axis. Notably, fewer HRRs are included in this figure than are used in our analysis due to privacy limitations. The black horizontal line is the mean among the HRRs. The red dots represent the mean of the individual HRR. Panel A, Adherence (mean 75%), defined as proportion of days covered > 80%. Panel B, Monthly out-of-pocket payment (mean $601), defined as total amount patient paid out-of-pocket, divided by the number of days filled *30. Panel C, Total out-of-pocket payment (mean $3,176), defined as total out-of-pocket payment in the first 180 days of treatment.